⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ZYME News
Zymeworks Inc.
Zymeworks Provides Corporate Update and Reports Second Quarter 2026 Financial Results
globenewswire.com
ZYME
Zymeworks Provides Corporate Update and Reports Second Quarter 2026 Financial Results
globenewswire.com
ZYME
Zymeworks to Report Second Quarter 2026 Financial Results on August 6, 2026
globenewswire.com
ZYME
A Clinical-Stage Cancer Company Is Putting AI to Work at the Bench, Designing Its Next Generation of Tumor-Targeting Drugs
prnewswire.com
GTBP
XNCR
CTMX
ZYME
NRIX
Form 8-K
sec.gov
ZYME
Zymeworks to Acquire Theravance Biopharma, Inc.
globenewswire.com
ZYME
TBPH
Gandeeva and Zymeworks Use Cryo-EM to Accelerate Antibody Drug Discovery
prnewswire.com
ZYME
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026
globenewswire.com
ZYME
Form 8-K
sec.gov
ZYME
Zymeworks Announces Share Repurchase Program of up to $125 Million of its Common Stock
globenewswire.com
ZYME